Skip to main content
Erschienen in: Archives of Osteoporosis 1/2023

01.12.2023 | Review

Frequency of osteoporosis in Chinese patients with rheumatoid arthritis: a meta-analysis

verfasst von: Tian-Xin Chen, Zhi-Long Zhang, Sheng-Ping Yang, Yu-Qi Zhu

Erschienen in: Archives of Osteoporosis | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Objective

To evaluate the current frequency of osteoporosis (OP) in Chinese patients with rheumatoid arthritis (RA) through meta-analysis.

Methods

The databases of PubMed, Web of Science, Cochrane Library, CNKI, Wan Fang, CBM, and VIP were searched for relevant literature regarding the occurrence of OP in Chinese patients with RA from January 1, 2000, to September 15, 2022. The literature was screened using inclusion and exclusion criteria, and qualifying articles were subjected to data extraction, quality evaluation, and meta-analysis using Stata 17.0 software.

Results

Altogether, 44 publications were included in this study, with a total sample size of 12,264 RA cases and 4532 patients with OP. Meta-analysis revealed that the frequency of OP in patients with RA was 37.67% [95% CI: 34.38%, 40.97%], while subgroup analysis showed that the frequency in South China was 49.43% [95% CI: 40.53%, 58.32%]. Also, the frequency in men was 29.29% [95% CI: 22.42%, 36.16%], which was significantly lower than in women (41.89% [95% CI: 36.87%, 46.90%]). The incidence rate in pre-menopausal women was only 15.19% [95% CI: 8.79%, 21.59%], much lower than the figure of 54.29% [95% CI: 45.28%, 63.30%] for post-menopausal women. Additionally, the frequency rates in the low, intermediate, and high disease activity groups were 24.52% [95% CI: 11.52%, 37.52%)], 27.67% [95% CI: 13.50%, 41.85%], and 57.96% [95% CI: 37.35%, 78.56%], respectively.

Conclusion

The frequency of OP in the Chinese RA population is higher than the world average, and patients with RA should receive standardized anti-RA therapy at an early stage, with emphasis on bone health in postmenopausal women, patients with high disease activity or longer disease duration.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
15.
Zurück zum Zitat Liu CP (2019) Analysis of the occurrence and related risk factors of SOPF in the patients with RA. Shandong First Medical University Liu CP (2019) Analysis of the occurrence and related risk factors of SOPF in the patients with RA. Shandong First Medical University
18.
Zurück zum Zitat Shen Y (2019) Analysis of bone metabolic markers in patients with rheumatoid arthritis and its correlation with TCM syndromes. Shanghai University of Traditional Chinese Medicine Shen Y (2019) Analysis of bone metabolic markers in patients with rheumatoid arthritis and its correlation with TCM syndromes. Shanghai University of Traditional Chinese Medicine
23.
Zurück zum Zitat Wang H (2014) The FRAX assessment of osteoporotic fracture risk in rheumatoid arthritis. WanNan Medical College Wang H (2014) The FRAX assessment of osteoporotic fracture risk in rheumatoid arthritis. WanNan Medical College
25.
Zurück zum Zitat Wang P (2020) Study on the relationship between related factors of rheumatoid arthritis secondary osteoporosis and TCM syndrome types. Shandong University of Traditional Chinese Medicine Wang P (2020) Study on the relationship between related factors of rheumatoid arthritis secondary osteoporosis and TCM syndrome types. Shandong University of Traditional Chinese Medicine
38.
Zurück zum Zitat Zhang S (2015) The clinical study on bone mineral density in female patients with rheumatoid arthritis. Bengbu Medical College Zhang S (2015) The clinical study on bone mineral density in female patients with rheumatoid arthritis. Bengbu Medical College
43.
Zurück zum Zitat Zou JM, Zhu LG, Yang J, Feng JF, Li SY, Luo JA, Li M, Ren Y, Dong JL, Zhang Y, Tian L (2022) Correlation between vitamin D metabolites and rheumatoid arthritis with osteoporosis by ultra-high-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). J Bone Miner Metab 40(4):696–703. https://​doi.​org/​10.​1007/​s00774-022-01337-3 CrossRef Zou JM, Zhu LG, Yang J, Feng JF, Li SY, Luo JA, Li M, Ren Y, Dong JL, Zhang Y, Tian L (2022) Correlation between vitamin D metabolites and rheumatoid arthritis with osteoporosis by ultra-high-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). J Bone Miner Metab 40(4):696–703. https://​doi.​org/​10.​1007/​s00774-022-01337-3 CrossRef
53.
68.
Zurück zum Zitat Abdulkhaliq A, Cheikh M, Almuntashri F, Alzahrani H, Nadwi H, Kadi E, Abed M, Janaini M, Monjed A, Janoudi N, Almoallim H (2021) A comparison of demographics, disease activity, disability, and treatment among rheumatoid arthritis patients with and without osteoporosis. Open Access Rheumatol 13:275–283. https://​doi.​org/​10.​2147/​OARRR.​S318810 CrossRef Abdulkhaliq A, Cheikh M, Almuntashri F, Alzahrani H, Nadwi H, Kadi E, Abed M, Janaini M, Monjed A, Janoudi N, Almoallim H (2021) A comparison of demographics, disease activity, disability, and treatment among rheumatoid arthritis patients with and without osteoporosis. Open Access Rheumatol 13:275–283. https://​doi.​org/​10.​2147/​OARRR.​S318810 CrossRef
79.
Zurück zum Zitat Zhang LL, Li LD, Hong XL, Guo ZX (2022) Meta-analysis of the prevalence of osteoporosis induced by systemic glucocorticoid in Chinese population. Mod Prev Med 12:2298–2304 Zhang LL, Li LD, Hong XL, Guo ZX (2022) Meta-analysis of the prevalence of osteoporosis induced by systemic glucocorticoid in Chinese population. Mod Prev Med 12:2298–2304
82.
Zurück zum Zitat Takeuchi T, Tanaka Y, Soen S, Yamanaka S, Yoneda T, Tanaka S, Nitta T, Okubo N, Genant HK, Heijde DVD (2019) Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial. Ann Rheum Dis 78(7):899–907. https://​doi.​org/​10.​1136/​annrheumdis-2018-214827 CrossRef Takeuchi T, Tanaka Y, Soen S, Yamanaka S, Yoneda T, Tanaka S, Nitta T, Okubo N, Genant HK, Heijde DVD (2019) Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial. Ann Rheum Dis 78(7):899–907. https://​doi.​org/​10.​1136/​annrheumdis-2018-214827 CrossRef
Metadaten
Titel
Frequency of osteoporosis in Chinese patients with rheumatoid arthritis: a meta-analysis
verfasst von
Tian-Xin Chen
Zhi-Long Zhang
Sheng-Ping Yang
Yu-Qi Zhu
Publikationsdatum
01.12.2023
Verlag
Springer London
Erschienen in
Archives of Osteoporosis / Ausgabe 1/2023
Print ISSN: 1862-3522
Elektronische ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-023-01212-2

Weitere Artikel der Ausgabe 1/2023

Archives of Osteoporosis 1/2023 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, DICOM-Daten, Videos und Abbildungen. » Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.